BioMedomics

About:

BioMedomics develops advanced quantitative point-of-care (POC) diagnostic platforms and disease-specific diagnostic tests.

Website: http://biomedomics.com

Twitter/X: BioMedomics

Top Investors: National Institutes of Health, Northern Light Venture Capital, NC IDEA

Description:

BioMedomics, Inc. manufactures and markets bioscience products and medical devices. The company’s products includes deoxyribonucleic acid research reagents; human, mouse, and rat genepool products; tissue array products; and antibodies. It designs and develops real-time cell electronic sensing technology for analyzing cell-based assay procedures. The company offers contract assay services such as cell proliferation, cytotoxicity, adhesion, viability, and invasion. Additionally, it provides drug discovery, research, and development services. BioMedomics is based in Research Triangle Park, North Carolina.